Alzheon
MA - Framingham
BiotechnologyFocus: Small Molecules targeting Alzheimer's
Alzheon is a life sciences company focused on Small Molecules targeting Alzheimer's.
Neurology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
ALZ-801 or matching placebo
Alzheimer DiseaseClinical Trials (1)
NCT04157712Multiple Ascending Dose Study of ALZ-801
Phase 1ALZ-801 170 mg Fasting
Alzheimer DiseaseClinical Trials (1)
NCT04585347Single Dose Study of ALZ-801 Prototype Tablets
Phase 1ALZ-801
Early Alzheimer's DiseaseClinical Trials (1)
NCT04693520Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease
Phase 2Experimental: ALZ-801
Early Alzheimer's DiseaseClinical Trials (1)
NCT06304883Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
Phase 3Experimental: ALZ-801
Early Alzheimer's DiseaseClinical Trials (1)
NCT04770220An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2013
Portfolio: 5 clinical trials